BRIEF — Cizzle Biotechnology and Cizzle Bio Achieve CLIA Validation

Oct 15 (Reuters) — Cizzle Biotechnology Holdings PLC: Cizzle Biotechnology - Update On Launch Of Lung Cancer Test In Usa Cizzle Biotechnology - Remaining $1.81 Million Guaranteed Advance Payments To Be Paid By Dec 31, 2027 Cizzle Biotechnology - Realigns Guaranteed Royalty Payments To December 2027; Option To Convert To Bio Stock Source text:... Further company coverage: CIZ.L (Reuters.Briefs@thomsonreuters.com)